Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hitt

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTAlan Desilva, Melinda Wuest, Monica Wang, et al.
Human Gene Therapy|February 10, 1996
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12J Bramson, M Hitt, W S Gallichan, et al.
Human Gene Therapy|October 20, 1996
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12J L Bramson, M Hitt, C L Addison, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cellsChang-Xin Shi, Michael A Long, Limin Liu, et al.
Gene Therapy|April 21, 2001
Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12Y Chen, P Emtage, Q Zhu, et al.
Gene Therapy|February 4, 1999
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsC L Addison, J L Bramson, M M Hitt, et al.
Human Gene Therapy|April 21, 1999
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer modelsP C Emtage, Y Wan, M Hitt, et al.
Cancer Letters|November 28, 2021
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinomaClayton J Bell, Kyle G Potts, Mary M Hitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritisE Parks, R M Strieter, N W Lukacs, et al.
International Journal of Cancer|April 15, 1990
Establishment of immortalized primate epithelial cells with sub-genomic EBV DNAL Karran, C G Teo, D King, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
American Journal of Nuclear Medicine and Molecular Imaging|November 8, 2012
Comparative functional evaluation of immunocompetent mouse breast cancer models established from PyMT-tumors using small animal PET with [(18)F]FDG and [(18)F]FLTAlan Desilva, Melinda Wuest, Monica Wang, et al.
Human Gene Therapy|February 10, 1996
Construction of a double recombinant adenovirus vector expressing a heterodimeric cytokine: in vitro and in vivo production of biologically active interleukin-12J Bramson, M Hitt, W S Gallichan, et al.
Human Gene Therapy|October 20, 1996
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12J L Bramson, M Hitt, C L Addison, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2004
The human SCGB2A2 (mammaglobin-1) promoter/enhancer in a helper-dependent adenovirus vector directs high levels of transgene expression in mammary carcinoma cells but not in normal nonmammary cellsChang-Xin Shi, Michael A Long, Limin Liu, et al.
Gene Therapy|April 21, 2001
Induction of ErbB-2/neu-specific protective and therapeutic antitumor immunity using genetically modified dendritic cells: enhanced efficacy by cotransduction of gene encoding IL-12Y Chen, P Emtage, Q Zhu, et al.
Gene Therapy|February 4, 1999
Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumorsC L Addison, J L Bramson, M M Hitt, et al.
Human Gene Therapy|April 21, 1999
Adenoviral vectors expressing lymphotactin and interleukin 2 or lymphotactin and interleukin 12 synergize to facilitate tumor regression in murine breast cancer modelsP C Emtage, Y Wan, M Hitt, et al.
Cancer Letters|November 28, 2021
Novel colchicine derivative CR42-24 demonstrates potent anti-tumor activity in urothelial carcinomaClayton J Bell, Kyle G Potts, Mary M Hitt, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 9, 1998
Transient gene transfer of IL-12 regulates chemokine expression and disease severity in experimental arthritisE Parks, R M Strieter, N W Lukacs, et al.
International Journal of Cancer|April 15, 1990
Establishment of immortalized primate epithelial cells with sub-genomic EBV DNAL Karran, C G Teo, D King, et al.
Pageof 10